Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04413201
Title AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients With EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Michael Hopp
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Klinikum der Ludwig-Maximilians-Universität München München Bayern 80336 Germany Details
Universitätsklinikum Gießen Marburg Gießen Hessen 35392 Germany Details
Sana-Klinikum Offenbach Offenbach Hessen 63069 Germany Details
Evangelische Lungenklinik Berlin Berlin 13125 Germany Details
Klinikum Bremen-Ost Bremen 28325 Germany Details
Studiengesellschaft Hämato-Onkologie Hamburg Hamburg 20251 Germany Details
Evangelisches Krankenhaus Hamm Hamm 59063 Germany Details
Klinikverbund Allgäug gGmbH, Klinik für Pneumologie, c/o Klinik Immenstadt 87509 Germany Details
Gemeinnützige Krankenhausbetriebsgesellschaft Konstanz Mbh Konstanz 78464 Germany Details
Klinik Löwenstein gGmbH Löwenstein 74245 Germany Details
Universitätsklinikum Regensburg Regensburg 93053 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field